Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Regeneron Pharmaceuticals Inc. sell geldnutzer

Start price
€437.60
19.11.20
Target price
€426.00
Performance (%)
1.19%
End price
€442.80
23.11.20
This prediction ended on 23.11.20 with a price of €442.80. The SELL prediction by geldnutzer shows the price for Regeneron Pharmaceuticals Inc. slightly increased by 1.19% during the runtime of the prediction. geldnutzer has a follow-up prediction for Regeneron Pharmaceuticals Inc., but this time predicts that Regeneron Pharmaceuticals Inc. is a Buy.

According to geldnutzer what are the pros and cons of Regeneron Pharmaceuticals Inc. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
Small challenges to pay loans and raise capital
Very valuable balance sheet
Top Rating
Very positive Cash Flow expected
Capable Management
Leading role in innovation
Strong uniques
Very differentiated customer and product portfolio
Growths much faster than the competition
Sustainability is important
Stable Large shareholder and/or long term investor
Small Risks for its business
Market Leader or Top 3
Very small cyclical dependencies
Well known brand
Very Future proof/growth oriented business model
Cons

Comments by geldnutzer for this prediction

In the thread Regeneron Pharmaceuticals Inc. diskutieren
Published 19.11.20
Prediction Sell
Perf. (%) 1.19%
Target price 426.000
Change

Sell mit Kursziel 426,0

In the thread Trading Regeneron Pharmaceuticals Inc.
Published 23.11.20
Prediction Buy
Perf. (%) 1.19%
Target price 426.000
Change

Sell beendet

Current prediction by geldnutzer for Regeneron Pharmaceuticals Inc.

buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€442.80
€456.00
-4.18%

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation

Stopped prediction by geldnutzer for Regeneron Pharmaceuticals Inc.

buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€453.60
€526.00
-3.53%

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation